#drug-approvals

[ follow ]
#fda #staffing-and-morale #regulatory-uncertainty #regulatory-delays #manufacturing-inspections
#fda
fromAxios
8 hours ago
Public health

Chaos at the FDA leaves staffers disturbed, ready to leave

Internal turmoil and leadership controversies at the FDA are driving experienced staff departures and hindering recruitment, threatening regulatory predictability for pharma and biotech.
fromArs Technica
1 week ago
Public health

FDA slows down on drug reviews, approvals amid Trump admin chaos

FDA drug approvals slowed, review delays and rejections increased, manufacturing inspection issues rose, and a government shutdown prevents accepting new drug submissions.
more#fda
from24/7 Wall St.
3 weeks ago

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Oct 2025)

From late 2020 to the summer of 2024, Eli Lilly & Co. ( NYSE: LLY) stock was on a tear, up more than 635%. Last year was a transformative year for the Indianapolis-based pharmaceutical giant, with substantial financial growth driven by its innovative medicines, significant regulatory successes, and continued investment in its pipeline and manufacturing capabilities. On the other hand, it did experience a revenue shortfall in the fourth quarter.
Business
[ Load more ]